A local startup, MediPharm Labs, has commenced the process for its shares to be listed on the TSX Venture Exchange (the “TSXV”).
On May 15, POCML 4 Inc., a TSXV capital pool company, signed a binding agreement with MediPharm Labs Inc. outlining the general terms and conditions for a reverse takeover of POCML 4 by MediPharm Labs.
Upon completion of the reverse takeover, MediPharm Labs will be a publicly traded company.
To stay up to date on investment opportunities, be sure to subscribe to MediPharm Labs news updates by entering your details below.
Friends, family and followers of MediPharm Labs know this comes as the result of a long and momentous journey. The next phase of MediPharm Labs promises to bring even greater achievements and innovations in cannabis oil extraction. Formed in 2015, MediPharm Labs recently became the first Canadian company to have successfully achieved Licensed Producer status without first receiving a cultivation license. The MediPharm Labs team is ready and eager to step up once again, and embrace the incredible potential of a public listing.